| In
2005, the US Food and Drug Administration (FDA) approved PEGASYS for the treatment
of chronic hepatitis B. Already the most prescribed hepatitis C medication in
the United States, PEGASYS is the first and only pegylated
interferon approved for the treatment of chronic hepatitis B, including both main
types of the virus. PEGASYS
helps in two important ways: -
PEGASYS slows replication of the hepatitis B virus.
- PEGASYS boosts the body's
immune system.
Pegasys
Product Information
(Pegasys for treatment of Hepatitis B starts
on page 25 of PDF)
HBV
Pegasys Roche Web Page |
Articles on Pegasys (peginterferon alfa-2a) for Treatment of Hepatitis B
FDA-approved
Combination Therapies for Chronic HBV Infection
